Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.903 |
High Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.903 |
High Similarity |
NPD1613 |
Approved |
0.9015 |
High Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8939 |
High Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8769 |
High Similarity |
NPD1610 |
Phase 2 |
0.8593 |
High Similarity |
NPD4908 |
Phase 1 |
0.8519 |
High Similarity |
NPD2861 |
Phase 2 |
0.8467 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8394 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.8321 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.8261 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.8088 |
Intermediate Similarity |
NPD4749 |
Approved |
0.8082 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.8077 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7975 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7974 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7943 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7922 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7832 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7832 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7832 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.78 |
Intermediate Similarity |
NPD1511 |
Approved |
0.777 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7722 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7707 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7697 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7655 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7635 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7635 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7635 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7606 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.76 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7597 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7595 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.758 |
Intermediate Similarity |
NPD2801 |
Approved |
0.758 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7571 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7568 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7568 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7537 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7535 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7533 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7519 |
Intermediate Similarity |
NPD228 |
Approved |
0.7517 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7517 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD37 |
Approved |
0.75 |
Intermediate Similarity |
NPD3021 |
Approved |
0.75 |
Intermediate Similarity |
NPD7228 |
Approved |
0.75 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7485 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7484 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7484 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7484 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7467 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7448 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7447 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7447 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7447 |
Intermediate Similarity |
NPD5327 |
Phase 3 |
0.7429 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7403 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7403 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7394 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7376 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7365 |
Intermediate Similarity |
NPD6353 |
Approved |
0.7358 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7349 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7347 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7347 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7338 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7338 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7305 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7305 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7305 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7299 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7297 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7297 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7297 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7294 |
Intermediate Similarity |
NPD8053 |
Approved |
0.7294 |
Intermediate Similarity |
NPD8054 |
Approved |
0.7292 |
Intermediate Similarity |
NPD4624 |
Approved |
0.729 |
Intermediate Similarity |
NPD4160 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7267 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7267 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7255 |
Intermediate Similarity |
NPD7466 |
Approved |
0.7255 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7248 |
Intermediate Similarity |
NPD2157 |
Approved |
0.7246 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7244 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7239 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7237 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD3094 |
Phase 2 |
0.7215 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7205 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7205 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7203 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7202 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7183 |
Intermediate Similarity |
NPD3092 |
Approved |
0.7179 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7174 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7172 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.717 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7169 |
Intermediate Similarity |
NPD2489 |
Approved |
0.7169 |
Intermediate Similarity |
NPD27 |
Approved |
0.7164 |
Intermediate Similarity |
NPD2684 |
Approved |
0.716 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.716 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7154 |
Intermediate Similarity |
NPD1242 |
Phase 1 |
0.7153 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.7152 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7152 |
Intermediate Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7152 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7152 |
Intermediate Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD968 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6331 |
Phase 2 |
0.7135 |
Intermediate Similarity |
NPD4578 |
Approved |
0.7135 |
Intermediate Similarity |
NPD4577 |
Approved |
0.7133 |
Intermediate Similarity |
NPD4097 |
Suspended |
0.7126 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7124 |
Intermediate Similarity |
NPD7037 |
Approved |
0.7118 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7117 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7117 |
Intermediate Similarity |
NPD7831 |
Phase 2 |
0.7117 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7117 |
Intermediate Similarity |
NPD7833 |
Phase 2 |
0.7117 |
Intermediate Similarity |
NPD7832 |
Clinical (unspecified phase) |
0.7117 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7111 |
Intermediate Similarity |
NPD4750 |
Phase 3 |
0.711 |
Intermediate Similarity |
NPD4663 |
Approved |
0.7108 |
Intermediate Similarity |
NPD2969 |
Approved |
0.7108 |
Intermediate Similarity |
NPD2970 |
Approved |
0.7097 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7097 |
Intermediate Similarity |
NPD2677 |
Approved |
0.7091 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.709 |
Intermediate Similarity |
NPD290 |
Approved |
0.7086 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7086 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7086 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.708 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7078 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7076 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7076 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7067 |
Intermediate Similarity |
NPD3657 |
Discovery |
0.7063 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7063 |
Intermediate Similarity |
NPD4678 |
Approved |
0.7059 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.7048 |
Intermediate Similarity |
NPD3051 |
Approved |
0.7048 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7042 |
Intermediate Similarity |
NPD5846 |
Approved |
0.7042 |
Intermediate Similarity |
NPD6516 |
Phase 2 |
0.7039 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7039 |
Intermediate Similarity |
NPD5960 |
Phase 3 |
0.7037 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7035 |
Intermediate Similarity |
NPD7313 |
Approved |
0.7035 |
Intermediate Similarity |
NPD7311 |
Approved |
0.7035 |
Intermediate Similarity |
NPD7312 |
Approved |
0.7035 |
Intermediate Similarity |
NPD7310 |
Approved |
0.7032 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7032 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7027 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7025 |
Intermediate Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.7021 |
Intermediate Similarity |
NPD3091 |
Approved |
0.7019 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7018 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7014 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7014 |
Intermediate Similarity |
NPD1840 |
Phase 2 |
0.7006 |
Intermediate Similarity |
NPD7040 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD7041 |
Phase 2 |
0.7 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.7 |
Intermediate Similarity |
NPD943 |
Approved |
0.7 |
Intermediate Similarity |
NPD1240 |
Approved |
0.6994 |
Remote Similarity |
NPD2560 |
Approved |
0.6994 |
Remote Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.6994 |
Remote Similarity |
NPD2563 |
Approved |
0.6994 |
Remote Similarity |
NPD7309 |
Approved |
0.6993 |
Remote Similarity |
NPD2796 |
Approved |
0.6993 |
Remote Similarity |
NPD1551 |
Phase 2 |
0.6993 |
Remote Similarity |
NPD3539 |
Phase 1 |
0.6988 |
Remote Similarity |
NPD8127 |
Discontinued |
0.6986 |
Remote Similarity |
NPD2797 |
Approved |
0.6982 |
Remote Similarity |
NPD3751 |
Discontinued |
0.698 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6977 |
Remote Similarity |
NPD7808 |
Phase 3 |
0.6971 |
Remote Similarity |
NPD7906 |
Approved |
0.697 |
Remote Similarity |
NPD846 |
Approved |
0.697 |
Remote Similarity |
NPD940 |
Approved |
0.6968 |
Remote Similarity |
NPD5177 |
Phase 3 |
0.6966 |
Remote Similarity |
NPD6583 |
Phase 3 |
0.6966 |
Remote Similarity |
NPD6582 |
Phase 2 |
0.6962 |
Remote Similarity |
NPD1754 |
Clinical (unspecified phase) |
0.6954 |
Remote Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.6954 |
Remote Similarity |
NPD230 |
Phase 1 |
0.6951 |
Remote Similarity |
NPD7768 |
Phase 2 |
0.6946 |
Remote Similarity |
NPD6071 |
Discontinued |
0.6943 |
Remote Similarity |
NPD7124 |
Phase 2 |
0.6943
|
Remote Similarity |
NPD5058 |
Phase 3 |